Barinthus Biotherapeutics PLC
NASDAQ:BRNS
Barinthus Biotherapeutics PLC
NASDAQ:BRNS
Price:
0.61
USD
1.67%
Market Closed
Market Cap:
$24.9m
Cash Flow Statement
Cash Flow Statement
Barinthus Biotherapeutics PLC
Barinthus Biotherapeutics PLC
Currency: USD
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||||||||
| Net Income |
(49)
|
(46)
|
(51)
|
(33)
|
(1)
|
11
|
5
|
(15)
|
(55)
|
(77)
|
(73)
|
(71)
|
(64)
|
(58)
|
(61)
|
(65)
|
(70)
|
(76)
|
|
| Depreciation & Amortization |
0
|
0
|
1
|
1
|
2
|
3
|
4
|
5
|
5
|
5
|
5
|
6
|
6
|
6
|
6
|
6
|
7
|
6
|
|
| Change in Deffered Taxes |
(0)
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(4)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Stock-Based Compensation |
13
|
16
|
16
|
20
|
14
|
11
|
10
|
8
|
7
|
6
|
5
|
4
|
4
|
5
|
5
|
4
|
2
|
0
|
|
| Other Non-Cash Items |
23
|
25
|
25
|
20
|
(4)
|
(25)
|
(15)
|
(13)
|
8
|
19
|
14
|
9
|
5
|
15
|
24
|
26
|
27
|
28
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
2
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
(7)
|
(8)
|
(7)
|
(18)
|
(20)
|
1
|
(4)
|
17
|
27
|
15
|
6
|
(1)
|
0
|
(23)
|
3
|
1
|
(2)
|
11
|
|
| Cash from Operating Activities |
(34)
N/A
|
(30)
+12%
|
(33)
-10%
|
(31)
+4%
|
(25)
+20%
|
(11)
+56%
|
(14)
-30%
|
(11)
+24%
|
(20)
-78%
|
(43)
-118%
|
(51)
-19%
|
(60)
-17%
|
(55)
+8%
|
(62)
-13%
|
(29)
+53%
|
(32)
-11%
|
(38)
-19%
|
(31)
+20%
|
|
| Investing Cash Flow | |||||||||||||||||||
| Capital Expenditures |
(1)
|
(1)
|
(1)
|
(2)
|
(4)
|
(6)
|
(6)
|
(8)
|
(9)
|
(6)
|
(5)
|
(3)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
(12)
|
0
|
0
|
(11)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(1)
N/A
|
(1)
-3%
|
(13)
-1 308%
|
(14)
-5%
|
(15)
-14%
|
(17)
-12%
|
(6)
+67%
|
(7)
-25%
|
(8)
-14%
|
(6)
+24%
|
(5)
+12%
|
(3)
+41%
|
(0)
+88%
|
(0)
-20%
|
(1)
-93%
|
(1)
+34%
|
(0)
+27%
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||||||||||
| Net Issuance of Common Stock |
228
|
228
|
228
|
103
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
|
| Net Issuance of Debt |
0
|
16
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(4)
|
(5)
|
(5)
|
(2)
|
(1)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Financing Activities |
266
N/A
|
239
-10%
|
223
-7%
|
101
-55%
|
(2)
N/A
|
(0)
+90%
|
0
N/A
|
2
+569%
|
2
+1%
|
2
+2%
|
2
-17%
|
1
-63%
|
1
+48%
|
1
+41%
|
2
+51%
|
2
-23%
|
1
-22%
|
1
-36%
|
|
| Change in Cash | |||||||||||||||||||
| Effect of Foreign Exchange Rates |
1
|
(5)
|
(6)
|
(11)
|
(9)
|
(5)
|
0
|
7
|
6
|
7
|
2
|
1
|
(1)
|
6
|
(2)
|
2
|
7
|
(1)
|
|
| Net Change in Cash |
232
N/A
|
204
-12%
|
171
-16%
|
45
-74%
|
(51)
N/A
|
(34)
+34%
|
(20)
+42%
|
(9)
+53%
|
(19)
-108%
|
(40)
-106%
|
(52)
-31%
|
(61)
-17%
|
(55)
+10%
|
(54)
+2%
|
(30)
+45%
|
(29)
+1%
|
(30)
-2%
|
(30)
-1%
|
|
| Free Cash Flow | |||||||||||||||||||
| Free Cash Flow |
(35)
N/A
|
(30)
+12%
|
(34)
-11%
|
(33)
+2%
|
(29)
+13%
|
(17)
+41%
|
(21)
-21%
|
(19)
+10%
|
(28)
-51%
|
(49)
-74%
|
(56)
-15%
|
(63)
-11%
|
(55)
+12%
|
(62)
-13%
|
(30)
+52%
|
(33)
-9%
|
(39)
-18%
|
(31)
+20%
|
|
Switch to:
Switch to:
See Also
Discover More
